Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TEM · against 134 other Healthcare companies of similar size
Ranked #115 of 135 · scores higher than 0% of peers
Bars: peers in each 10-point band of the valuation score21 peers with a valuation score of 0–9, including TEM · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | TEM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 133 reported | -1.9% | 2.7% | 14% | 30% | |
| EBITDA yieldHigher is better · 136 reported | -1.3% | 4.8% | 15% | 50% | |
| Free cash flow yieldHigher is better · 88 reported | -1.9% | 2.9% | 17% | 20% | |
| Book yieldHigher is better · 133 reported | 3.2% | 20.5% | 8% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 2 | 10.4B USD | 96 | 64 | |
| 3 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 3 | 21.5B USD | 95 | 60 | |
| 5 | 11.6B USD | 94 | 58 | |
| 115 | 9.0B USD | 8 | 33 | |
| 115 | 7.8B USD | 8 | 30 | |
| 115 | 26.0B USD | 8 | 28 | |
| 115 | 12.6B USD | 8 | ||
| 115 | 14.0B USD | 8 | 31 | |
| 115 | 9.3B USD | 8 | 29 | |
| 115 | 8.5B USD | 8 | 28 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score